Skip to main content

Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More

COVID-19 Updates

COVID-19 Updates: Get the latest on vaccine information, in-person appointments, virtual visits and more. Learn More


Texas Medical Center

Cancer and Hematology
Phone: 832-822-4242
Office Phone


6701 Fannin St., Ste. 1510
Houston, TX 77030

Sarah B. Whittle, MD

Director, Soft Tissue Sarcoma Program
Clinical Research Team Lead, Solid Tumor Programs
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine


School Education Degree Year
Baylor College of Medicine Masters Master of Science, Clinical Investigation 2016
Baylor College of Medicine Fellowship Solid Tumors 2016
Baylor College of Medicine Fellowship Pediatric Hematology-Oncology 2015
Hasbro Children's Hospital, Brown University Residency Pediatrics 2012
Warren Alpert Medical School at Brown University Medical School Doctor of Medicine 2009
Tufts University Bachelors Bachelor of Arts, Biology 2005


Dr. Sarah Whittle is the Director of the Soft Tissue Sarcoma Program at Texas Children's Hospital and the leader of the solid tumor clinical research team. She has served as the principal investigator for several clinical trials related to pediatric solid tumors, and is nationally recognized for her expertise in the care of children with these diseases.  

Dr. Whittle attended the Warren Alpert School of Medicine at Brown University for medical school, and remained at Brown for her pediatric residency training. She then completed her pediatric hematology-oncology fellowship at Baylor College of Medicine/Texas Children's Hospital, and completed an additional year of training to further specialize in the treatment of pediatric solid tumors. She holds a masters degree in clinical investigation from Baylor College of Medicine. At the national level, Dr. Whittle is a member of the Children's Oncology Group Bone and Soft Tissue Sarcoma committees, and is involved with planning upcoming clinical trials within these groups.

Dr. Whittle treats patients with all pediatric solid tumors including neuroblastoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, and other rare bone and soft tissue sarcomas including synovial sarcoma, liposarcoma, BCOR and CIC-DUX sarcomas, alveolar soft parts sarcoma, and others.  

She is board certified by the American Academy of Pediatrics in Pediatrics and in Pediatric Hematology/Oncology. 


Organization Name Role
American Academy of Pediatrics (AAP) Member
American Society of Pediatric Hematology and Oncology (ASPHO) Member
Children’s Oncology Group (COG) Member
Connective Tissue Oncology Society (CTOS) Member

Research Statement

Dr. Whittle is an expert in the design and conduct of clinical trials for pediatric solid tumors. She has served as principal investigator of several investigator initiated, cooperative group, and industry sponsored clinical trials, and currently leads a Children's Oncology Group national phase I-II clinical trial investigating a new agent for use in pediatric solid tumors and lymphoma. At Texas Children's, she is the team leader for clinical research and oversees the conduct of studies that enroll pediatric and adolescent young adult solid tumor patients.

Awards & Honors

2021     Early Career Faculty Award for Excellence in Clinical Care, Baylor College of Medicine



* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.